Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: A study in isolated rat hepatocyte couplets

Hepatology

Volumn 29, Issue 2, 1999, Pages 471-476

  Milkiewicz, Piotr ^a   Mills, Charles O ^a   Roma, Marcelo G ^b   Ahmed Choudhury, Jalal ^b   Elias, Elwyn ^a   Coleman, Roger ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; LIVER PROTECTIVE AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; S ADENOSYLMETHIONINE; TAUROLITHOCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID;

ANIMAL CELL; ARTICLE; BILE FLOW; CHOLESTASIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INDUCED DISEASE; DRUG POTENTIATION; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BILE ACIDS AND SALTS; BILE CANALICULI; CHOLESTASIS; FLUORESCENT DYES; MALE; RATS; RATS, WISTAR; S-ADENOSYLMETHIONINE; TAUROCHENODEOXYCHOLIC ACID; TAUROLITHOCHOLIC ACID; VACUOLES;

EID: 0033024498     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290215     Document Type: Article

References (23)

1. Javitt NB. Cholestasis in rats induced by taurolithocholate. Nature 1966;210:1262-1263.
2. Yousef IM, Tuchweber B, Vonk RJ, Masse D, Audet M, Roy CC. Lithocholate cholestasis-sulfated glycolithocholate-induced intrahepatic cholestasis in rats. Gastroenterology 1981;80:233-241.
3. Kakis G, Yousef IM. Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats. Gastroenterology 1978;75:595-607.
4. Javitt NB, Emerman S. Effect of sodiun taurolithocholate on bile flow and bile salt excretion. J Clin Invest 1968; 47:1002-1014.
5. Thibault N, Maurice M, Maratrat M, Cordier A, Feldman G, Ballet F. Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocytes couplets. J Hepatol 1993;19:367-376.
6. Vu DD, Tuchweber B, Raymond P, Yousef IM. Tight junction permeability and liver plasma membrane fluidity in lithocholate induced cholestasis. Exp Mol Pathol 1992;57:47-61.
7. Roma MG, Penalva GL, Aguero RM, Rodriguez Garay EA. Hepatic transport of organic anions in taurolithocholate induced cholestasis in rats. J Hepatol 1994;20:603-610.
8. Reichen J, Paumgartner G. Inhibition of hepatic Na/K adenosinetriphosphatase in taurolithocholate induced cholestasis. Experientia 1979;35:1186-1188.
9. Marteau P, Chazouilleres O, Myara A, Jian R, Rambaud JC, Poupon R. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. HEPATOLOGY 1990;12:1206-1208.
10. Guarantz D, Hofmann AF. Influence of bile acid structure on bile flow and biliary lipid secretion in hamster. Am J Physiol 1984;247:G736-G748.
11. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and II major histocompatibility complex molecules in primary, biliary cirrhosis: effect of ursodeoxycholic acid. HEPATOLOGY 1990;11:12-15.
12. Gulduntuna S, Zimmer G, Imhof M, Bhatti S, You T, Leuschner U. Molecular aspects of membrane stabilisation by ursodeoxycholate. Gastroenterology 1993;104:1736-1744.
13. Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 1991;100:203-211.
14. Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985;248:G407-G417.
15. Friedel HA, Goa KL, Benfield P. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and disorders in relation to its physiological role in cell metabolism. Drugs 1989;38:389-416.
16. Owen JS, Rafique S, Osman E, Burroughs AK. Ability of S-adenosyl-L-methionine to ameliorate lipoprotein induced membrane lipid abnormalities and cellular dysfunction in human liver disease. Drug Inv 1992;4:22-40.
17. Boelsterli UA, Rakhit G, Balazs T. Modulation by S-adenosyl-L-methionine of hepatic Na/K-ATPase, membrane fluidity and bile flow in rats with ethynyl estradiol induced cholestasis. HEPATOLOGY 1983;3:12-17.
18. Corrales F, Ochoa P, Rivas C, Martin-Lomas M, Mato JM. Inhibition of glutathione synthesis leads to S-adenosyl-L-methionine synthetase reduction. HEPATOLOGY 1991;14:528-533.
19. Martin-Duce A, Oritz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. HEPATOLOGY 1988;8:65-68.
20. Stramentinoli G, Di Padova C, Gualano M, Rovagnati P, Galli-Kienle M. Ethynyl estradiol induced impairment of bile secretion in the rat: Protective effect of S-adenosyl-L-methionine and its implication in estrogen metabolism. Gastroenterology 1981;80:154-158.
21. Roman I, Johnson GD, Coleman R. S-adenosyl-L-methionine prevents disruption of canalicular function and pericanalicular cytoskeleton integrity caused by cyclosporin A in isolated rat hepatocytes couplets. HEPATOLOGY 1996;24:134-140.
22. Mills CO, Rahman K, Coleman R, Elias E. Cholyl-lysylfluorescein: Synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver. Biochimica et Biophysica Acta 1991;1115:151-156.
23. Wilton JC, Williams DE, Strain AJ, Parslow RA, Chipman JK, Coleman R. Purification of hepatocyte couplets by centrifugal elutriation. HEPATOLOGY 1991;14:180-183.